Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by CancerVAX, Inc

News headline image
CancerVax Precision Therapy Successfully Avoids Healthy Liver Cells
From CancerVAX, Inc
Via GlobeNewswire
News headline image
Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Achieves Major Milestones and Files Foundational Patent Application
From CancerVAX, Inc
Via GlobeNewswire
News headline image
Scientists Discuss the Recent CancerVax Breakthrough
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
From CancerVAX, Inc
Via GlobeNewswire
News headline image
Top Biotech Exec Joins CancerVax as Chief Scientific Advisor
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Announces Successful Tests of its Smart mRNA Technology
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Passes First Test with Flying Colors
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Targets Hard to Treat Pancreatic Cancer
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Lands Top Cancer Expert
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Adds Key Members to Its Research Team
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVax Launches $5 Million Funding Round
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVAX CEO Ryan Davies Discusses Cancer Drug Development with Dr. Ezra Cohen
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVAX CEO Ryan Davies Discusses the Company’s Growing Pipeline of Cancer Treatments
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVAX Expands Development Pipeline to Include a Universal CAR-T Cell Platform
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVAX CEO Ryan Davies Discussed Cancer Immunotherapy with UCLA Physician-Scientist
From CancerVAX, Inc
Via GlobeNewswire
News headline image
World Renowned Biomedical Professor Jonathan Lakey Joins CancerVAX Board of Advisors
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr. Lara Sullivan
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA
From CancerVAX, Inc
Via GlobeNewswire
News headline image
Biotech Executive Michael Smith Discusses the FDA Drug Development Process with CancerVAX CEO Ryan Davies
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVAX Launches $10 Million Funding Round
From CancerVAX, Inc
Via GlobeNewswire
News headline image
CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment
From CancerVAX, Inc
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.